I-Ondansetron Hydrochloride Dihydrate CAS 103639-04-9 Assay 98.0 ~ 102.0%
I-Shanghai Ruifu Chemical ngumenzi ohamba phambili we-Ondansetron Hydrochloride Dihydrate (CAS: 103639-04-9) enomgangatho ophezulu.I-Ruifu inokubonelela ngenkonzo yehlabathi jikelele, ixabiso elikhuphisanayo, inkonzo egqwesileyo, amancinci kunye nezixa ezininzi ezikhoyo.Thenga i-Ondansetron Hydrochloride Dihydrate,Please contact: alvin@ruifuchem.com
AbaPhakathi abanxulumeneyo be-Ondansetron Hydrochloride Dihydrate
Igama leMchiza | Ondansetron Hydrochloride Dihydrate |
Izithethantonye | I-Ondansetron HCl Dihydrate;1,2,3,9-Tetrahydro-9-Methyl-3-[(2-Methyl-1H-imidazol-1-yl) methyl]-4H-Carbazol-4-one Hydrochloride Dihydrate;Emeset;GR 38032 Hydrochloride Dihydrate;SN 307 Hydrochloride Dihydrate;GR 3832 HCl 2H2O;SN-37 HCl 2H2O;NSC665799 HCl 2H2O |
Ubume beStokhwe | Kwisitokhwe, isikali soRhwebo |
Inombolo yeCAS | 103639-04-9 (Dihydrate) |
Enxulumene CAS RN | 99614-02-5 (Isiseko) & 99614-01-4 (Anhydrous) |
Ifomula yeemolekyuli | C18H19N3O·HCl·2H2O |
Ubunzima beMolekyuli | 365.86 g/mol |
Indawo yokunyibilika | 176.0 ukuya 180.0℃ |
Inovakalelo | Ubushushu Bubuthathaka |
Ukunyibilika kwamanzi | Inyibilika emanzini (>5 mg/ml) |
Ugcino Temp. | Indawo epholileyo neyomileyo (2~8℃) |
I-COA kunye ne-MSDS | Iyafumaneka |
Uphawu | Ruifu Chemical |
Izinto | ImiGangatho yokuHlola | Iziphumo |
Imbonakalo | Mhlophe ukuya kuMhlophe oMhlophe wePowder | Iyahambelana |
Ukuchongwa | ||
1. UV | Ubukhulu 209, 248, 267, 310nm | Ufanelekile |
2. I-IR spectrum | Iyahambelana neSakhiwo | Ufanelekile |
3. Ucalucalulo lweChloride | Phambili Ukusabela | Ufanelekile |
Amanzi nguKarl Fischer | 9.0~10.5% | 9.7% |
Intsalela kwi-Ignition | ≤0.10% | 0.03% |
Iintsimbi ezinzima (Pb) | ≤10ppm | <10ppm |
I-Ondansetron eNxulumene nayo iCompound C | ≤0.20% | 0.09% |
Ikhompawundi eNxulumene ne-Ondansetron D | ≤0.10% | 0.04% |
Imidazole | ≤0.20% | 0.02% |
2-Methylimidazole | ≤0.20% | 0.02% |
I-Ondansetron eNxulumene nayo iCompound A | ≤0.20% | 0.05% |
Okunye Ukungacoceki Okukodwa okungaziwayo | ≤0.10% | 0.07% |
Ukungcola ngokupheleleyo | ≤0.50% | 0.29% |
Intsalela yokunyibilika | ||
I-Ethanol | ≤5000ppm | 240ppm |
Isivavanyi | 98.0 ~ 102.0% (Ibalwe kwisiseko se-anhydrous) | 99.81% |
Ukuqukumbela | Imveliso ivavanyiwe kwaye iyahambelana neenkcukacha |
Umqulu:Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwisitya esivaliweyo.Gcina kwindawo epholileyo, eyomileyo (2~8℃) kunye nendawo yokugcina impahla engenamoya kude nezinto ezingahambelaniyo.Khusela ukukhanya kunye nokufuma.
Ukuhambisa ngenqanawe:Zisa kwihlabathi liphela ngomoya, ngeFedEx / DHL Express.Ukubonelela ngokukhawuleza nangokuthembekileyo.
Ukuthenga njani?Nceda uqhagamshelaneDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
Amava Eminyaka Eli-15?Sineminyaka engaphezu kwe-15 yamava ekwenziweni nasekuthumeleni kumazwe angaphandle uluhlu olubanzi oluphezulu lwamayeza aphakathi okanye amachiza alungileyo.
Iimarike eziphambili?Thengisa kwimarike yasekhaya, eMntla Melika, eYurophu, eIndiya, eKorea, eJapan, eOstreliya, njl.
Iingenelo?Umgangatho ophezulu, ixabiso elifikelelekayo, iinkonzo zengcali kunye nenkxaso yobugcisa, ukuhanjiswa ngokukhawuleza.
UmgangathoIsiqinisekiso?Inkqubo yokulawula umgangatho ongqongqo.Izixhobo zobuchwephesha zokuhlalutya ziquka i-NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, njl.
Iisampulu?Uninzi lweemveliso zibonelela ngeesampulu zasimahla zokuvavanya umgangatho, iindleko zokuthumela kufuneka zihlawulwe ngabathengi.
Factory Audit?Uphicotho-zincwadi lwasefektri wamkelekile.Nceda wenze idinga kwangaphambili.
MOQ?Akukho MOQ.Umyalelo omncinci wamkelekile.
Ixesha lokuzisa? Ukuba ngaphakathi kwesitokhwe, ukuhanjiswa kweentsuku ezintathu kuqinisekisiwe.
Ezothutho?Nge-Express (FedEx, DHL), ngoMoya, ngoLwandle.
Amaxwebhu?Emva kwenkonzo yokuthengisa: I-COA, i-MOA, i-ROS, i-MSDS, njl.
Udibaniso lweSiko?Inokubonelela ngeenkonzo zesiko lokudibanisa ukuze zilungele iimfuno zakho zophando.
Immimiselo yokuhlawula?I-invoyisi yeProforma iya kuthunyelwa kuqala emva kokuqinisekiswa kwe-odolo, efakwe kwiinkcukacha zethu zebhanki.Intlawulo nge-T / T (i-Telex Transfer), i-PayPal, i-Western Union, njl.
Iikhowudi zoMngcipheko
I-R25 - Inetyhefu xa iginyiwe
R36/37/38 - Ukucaphukisa emehlweni, inkqubo yokuphefumla kunye nolusu.
Inkcazelo yoKhuseleko
S45 - Kwimeko yengozi okanye ukuba uziva ungaphilanga, funa ingcebiso kagqirha ngokukhawuleza (bonisa ileyibhile nanini na kunokwenzeka.)
I-S37/39 - Nxiba iiglavu ezifanelekileyo kunye nokukhusela amehlo / ubuso
S26 - Xa udibana namehlo, hlambulula ngokukhawuleza ngamanzi amaninzi kwaye ufune iingcebiso zonyango.
Ii-ID ze-UN UN 2811 6.1/PG 3
WGK eJamani 3
RTECS FE6375500
Ikhowudi yeHS 29339900
Udidi lweeNgozi 6.1(a)
Ukupakisha Iqela II
I-Ondansetron Hydrochloride Dihydrate (CAS: 103639-04-9) i-serotonin ethile (5-HT3) i-receptor antagonist.I-Antiemetic.I-Ondansetron Hydrochloride Dihydrate isetyenziselwa ukukhusela isicaphucaphu kunye nokuhlanza okunokuthi kubangelwa utyando, i-chemotherapy yomhlaza, okanye unyango lwe-radiation.I-5-HT3 ye-receptor antagonists e-Ondansetron ziziyobisi eziphambili ezisetyenziselwa ukunyanga nokukhusela i-chemotherapy-induced nausea kunye nokuhlanza kunye ne-radiotherapy-induced-induced nausea kunye nokuhlanza, ngokuthintela izenzo zeekhemikhali emzimbeni.Ukusebenza kakuhle kune-metoclopramide ngelixa i-sedating encinci kune-cyclizine okanye i-droperidol.Nangona kunjalo, ayinayo impembelelo encinci ekugabheni okubangelwa sisifo sokuhamba.Inokunikelwa ngomlomo, ngokutofa kwisihlunu okanye kumthambo.
I-Ondansetron kunye ne-Granisetron, i-Dolasetron zintathu eziqhelekileyo ezisetyenziswa kwikliniki ye-antiemetics, i-ondansetron i-serotonin esebenzayo (i-5-HT3) i-receptor blocker eguqulwayo kwaye ikhethe, i-α1, i-α2, i-β1, i-β2-adrenergic receptors kunye ne-histamine H1, i-H2 receptors, inesiphumo esincinci, kwii-H receptors, i-central and peripheral dopaminergic receptors, ayinayo isiphumo esichasayo, inokucinezela ichemotherapy kunye nesicaphucaphu kunye nokugabha.Xa kuthelekiswa ne-metoclopramide, impembelelo yayo ye-antiemetic yomelele kwaye ayinayo i-extrapyramidal reactions.Ukuhlanza okubangelwa yi-cisplatin, i-cyclophosphamide, i-doxorubicin, njl. inokuvelisa i-antiemetic ekhawulezayo kunye nenamandla.Ayifanelekanga kuphela kunyango lwesicaphucaphu kunye nokugabha okubangelwa yi-cytotoxic chemotherapy kunye nonyango lwemitha, kodwa kunye nokuthintela kunye nonyango lwesicaphucaphu kunye nokugabha okubangelwa lutyando.I-Ondansetron isebenza njengendawo yokuhamba phakathi kwe-nerve ye-visceral afferent esebenzayo kwi-gastrointestinal tract kunye neziko lokuhlanza ngaphakathi kwentambo yomgogodla, ekhokelela kwi-diaphragm kunye neentshukumo zesisu zesisu.I-Chemotherapy kunye nonyango lwe-radiation lunokubangela ukukhululwa kwe-intestinal 5-HT kwaye kubangele i-vagus nerve stimulation yi-5-HT3 receptor, ebangela ukuhlanza i-reflex.Le mveliso ithintela ukuba kwenzeke le reflex, kwangaxeshanye ivalela ukugabha okubangelwa sisenzo esiphakathi.Indlela malunga nesicaphucaphu kunye nokuhlanza emva kokuhlinzwa ayaziwa.I-Ondansetron idityaniswe ne-dexamethasonecan inokuphucula impembelelo yokuchasana nokuchachamba.
Oku kubangela ukukhutshwa kwe-vagal afferent, kubangela ukugabha.Ekubopheni i-5-HT3 receptors, i-ondansetron ibhloka i-serotonin stimulation, ngoko ke ukuhlanza, emva kwe-emetogenic stimuli efana ne-cisplatin.Intloko ebuhlungu yeyona nto ixhaphakileyo isiphumo esibi sala mayeza.
Ityhefu ngomzila womithanjana.Iimpembelelo zenkqubo yomntu ngomzila womthambo: ijaundice.Xa ishushu ukuze ibole ikhupha umphunga oyityhefu weNOx.
Isetyenziswa njenge-antiemetic xa i-antiemetics eqhelekileyo ingasebenzi, njengaxa uhambisa i-cisplatin okanye ezinye izizathu zokugabha okungapheliyo.Ukusetyenziswa kwe-ondansetron kwiikati kuyaphikisana kwaye ezinye zithi akufanele zisetyenziswe kule ntlobo.
Ukudibana kweziyobisi Ukudibana okunokuba yingozi namanye amachiza.
1,2,3,9-Tetrahydro-9-methyl-4H-carbazol-4-enye.
1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-enye.
Isisombululo esisemgangathweni | Ukunciphisa | Ugxininiso (µg RS ngemL) | Ipesenti (%, xa kuthelekiswa nomzekelo wovavanyo) |
A | (1 kwisi-5) | 50 | 0.4 |
B | (1 kwi-10) | 25 | 0.2 |
C | (1 kuma-20) | 12.5 | 0.1 |
Isisombululo sovavanyo-Dibanisa isixa esilinganiswe ngokuchanekileyo se-Ondansetron Hydrochloride kwi-methanol ukufumana isisombululo esiqulethe i-12.5 mg nge-mL.Inkqubo-Ngokwahlukileyo sebenzisa i-20 µL yesisombululo soVavanyo, i-20 µL yesisombululo soMgangatho ngamnye, kunye ne-20 µL yesisombululo kwipleyiti ecekethekileyo yechromatographic (bona iChromatography621) iqatywe nge-0.25-mm umaleko we-chromatographic umxube we-silica gel.Phuhlisa i-chromatogram kwinkqubo yokunyibilikisa equka umxube we-chloroform, i-ethyl acetate, i-methanol, kunye ne-ammonium hydroxide (90:50:40:1) de i-solvent front ihambe malunga nesithathu-esine ubude beplate.Susa ipleyiti kwigumbi, phawula i-solvent ngaphambili, kwaye uvumele i-solvent ukuba ibe ngumphunga.Jonga ipleyiti phantsi kokukhanya kwe-UV okufutshane: isisombululo esipheleleyo samacandelo amathathu eSigqibo sesisombululo sifunyenwe.Thelekisa ubunzulu bawo nawaphi na amachaphaza esibini aqatshelwe kwichromatogram yesisombululo soVavanyo kunye nalawo amabala aphambili kwichromatogram yezisombululo zoMgangatho: naliphi na ibala lesibini ukusuka kwichromatogram yesisombululo soVavanyo esinexabiso leRF elihambelana nelo lolona luphezulu lwesibini. indawo yesisombululo seSigqibo ayinkulu okanye inamandla ngaphezu kwendawo eyintloko efunyenwe kwisisombululo esisemgangathweni A (0.4%);kwaye akukho nenye indawo yesibini esuka kwichromatogram yesisombululo soVavanyo inkulu okanye iqine ngaphezu kwendawo ephambili efunyenwe kwisisombululo esiseMgangathweni B (0.2%).
apho i-C igxininise, kwi-mg nge-mL, ye-USP Ondansetron Hydrochloride RS kwisisombululo esiPhakathi;W ubunzima, kwi-mg, ye-Ondansetron Hydrochloride ethathwe ukulungiselela isisombululo soVavanyo;F yimpendulo ehambelanayo yokungcola njengoko kuchazwe kwitheyibhile ehamba kunye;ri yindawo encopho yokungcola ngakunye kwisisombululo soVavanyo;kunye ne-rS yindawo ephezulu ye-ondansetron efunyenwe kwisisombululo soMgangatho: ihlangabezana neemfuno ezinikwe kwitheyibhile ehamba kunye.
Igama loMdibaniso | Ixesha lokuGcina isihlobo | Isihlobo Impendulo Umba | Umda (%) |
---|---|---|---|
Ikhompawundi enxulumene ne-Ondansetron C | malunga ne-0.32 | 1.2 | 0.2 |
Ikhompawundi enxulumene ne-Ondansetron D* | malunga ne-0.34 | - | 0.1 |
Imidazole | malunga ne-0.49 | 0.3 | 0.2 |
2-methylimidazole | malunga ne-0.54 | 0.4 | 0.2 |
Ondansetron | 1.0 | - | - |
Ikhompawundi enxulumene ne-Ondansetron A | malunga ne-1.10 | 0.8 | 0.2 |
Akwaziwa | - | 1.0 | 0.1 |
Iyonke | - | - | 0.5 |
* Ibalwe kuvavanyo loMda we-ondansetron enxulumene nekhompawundi D. |
apho i-C igxininise, kwi-mg nge-mL, ye-USP Ondansetron Hydrochloride RS kulungiselelo oluMgangatho;kunye ne-rU kunye ne-rS ziindawo eziphakamileyo ezifunyenwe kulungiselelo loVavanyo kunye nolungiselelo loMgangatho, ngokulandelelanayo.
Indlela ye-1: Emva kokusabela kwe-2-Bromoaniline kunye1,3-Cyclohexanedione, i-derivative ye-tetrahydrocarbazole yenziwe, kwaye i-compound (III) ifunyenwe ngokuphendula nge-dimethylamine kunye ne-diformaldehyde, kwaye ingenise i-dimethylaminomethyl kwi-2-position.I-3.80G ye-compound (III) yaphendulwa nge-methyl iodide ukunika i-5.72g ye-compound (IV) ngokudibanisa iqela le-amino yecala ngelixa lizisa iqela le-methyl kwindawo ye-9. 2.0g ye-compound (IV) kunye ne-2-methyl-1h. -imidazole yaphendulwa kwi-dimethylformamide ngokuvuselela kwi-95 ℃.Ukufumana i-0.60G ye-Ondansetron.
Indlela yesi-2: Ukusabela kwe-cyclohexanone kunye ne-phenylhydrazine wanika i-tetrahydrocarbazole kwi-85% yesivuno.Yinyibilikise kwi-tetrahydrofuran kunye namanzi, yongeza i-2,3 Dropwise kwi-0 ° c kwi-nitrogen, isisombululo se-5, i-6-tetrachloro-1,4-benzoquinone kwi-tetrahydrofuran yavuselelwa ukunika imveliso ye-oxidation (II) kwi-67.4% yesivuno.I-Compound (II), i-ethanol, i-hydrochloric acid, i-paraformaldehyde kunye ne-dimethylamine hydrochloride zaye zaxutywa kunye.Emva konyango, imveliso (V) yafunyanwa ngokudibanisa i-hydrochloric acid egxininisiweyo kwi-acetone kwaye ivuselela kwi-50 ℃.Kwisivuno se-71.7%.I-Compound (V) kunye ne-2-methylimidazole zaphendulwa emanzini kwi-110 ℃.Ukufumana i-compound (VI) kwi-70.9% yesivuno.ICompound (VI), methyl iodide kunye ne potassium carbonate zazanywa kwiqondo lobushushu begumbi de kwanyamalala okuqinileyo.Igalelwe emanzini, ixutywe, ihluzwe, ihlanjwe ngamanzi, kwaye iphinde ihlaziywe kwi-methanol ukuze ifumane i-ondansetron kwi-57.2% yesivuno.Uyichithe kumxube we-acetone kunye namanzi, Ngokudibanisa i-hydrochloric acid egxininisiweyo ekuphenduleni, i-ondansetron hydrochloride dihydrate yafunyanwa ngesivuno se-92.6%.
Indlela ye-3: i-compound (II), i-potassium carbonate, i-acetone kunye ne-dimethyl sulfate yaxutywa kwiqondo lokushisa.ICompound (VII) ifunyenwe ngesivuno sama-91%.I-Compound (VII) yachithwa kwi-ethanol kunye nomxube we-paraformaldehyde yabantu kunye ne-dimethylamine hydrochloride yongezwa kwiingxenye phantsi kwe-reflux.Ukuguquguquka.Emva kokunyanga, i-compound (VIII) ifunyenwe kwi-67% yesivuno.(Viii) inyibilikiswe kwi-ethanol ye-anhydrous, igesi ye-hydrogen chloride, i-hydrochloride yayo.I-hydrochloride yongezwa emanzini kwaye i-2 yongezwa kwi-50 ℃.I-Methylimidazole, i-ondansetron ye-refluxing, ivelisa i-70%.Yachithwa kwi-isopropanol, amanzi kunye ne-concentrated hydrochloric acid, kwaye ixutywe kwiqondo lokushisa lokushisa ukuze ifumane i-ondansetron hydrochloride dihydrate kwisivuno se-90.5%.